Cabell Huntington Hospital is a regional, 303-bed academic medical center located in Huntington, West Virginia. Cabell Huntington cares for patients from more than 29 counties in West Virginia, eastern Kentucky, and southern Ohio. It is one of the ten largest general hospitals in West Virginia.

There are 303 beds in Cabell-Huntington Hospital.

During the past decade, Cabell-Huntington Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cabell-Huntington Hospital" #1 sponsor was "Children's Oncology Group" with 23 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Marshall University" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Dascena" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cabell-Huntington Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Cabell Huntington Hospital" with 2 trials as a collaborator, "Children's Oncology Group" with 1 trials as a collaborator, "SWOG Cancer Research Network" with 1 trials as a collaborator and "University College London Hospitals" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Cabell-Huntington Hospital" are "Leukemia" (7 trials), "Sarcoma" (6 trials), "Brain and Central Nervous System Tumors" (4 trials), "Neuroblastoma" (4 trials) and "Kidney Cancer" (3 trials). Many other conditions were trialed in "Cabell-Huntington Hospital" in a lesser frequency.

Most popular intervention types in "Cabell-Huntington Hospital" are "Drug" (23 trials), "Biological" (12 trials), "Procedure" (10 trials), "Radiation" (9 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (10 trials), "filgrastim" (9 trials), "radiation therapy" (8 trials), "etoposide" (7 trials) and "doxorubicin hydrochloride" (6 trials). Other intervention names were less common.

The vast majority of trials in "Cabell-Huntington Hospital" are 29 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Cabell-Huntington Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Cabell-Huntington Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cabell-Huntington Hospital, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".